OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
This Quarter Return
+16.38%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$119M
AUM Growth
+$119M
(+20%)
Cap. Flow
+$7.41M
Cap. Flow
% of AUM
6.24%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
70
New
18
Increased
23
Reduced
15
Closed
4
Top Buys
| 1 |
Pacira BioSciences
PCRX
|
$3.11M |
| 2 |
Alkermes
ALKS
|
$2.62M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.15M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$2.04M |
| 5 |
Esperion Therapeutics
ESPR
|
$1.39M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$3.88M |
| 2 |
ProShares Ultra NASDAQ Biotechnology
BIB
|
$3.23M |
| 3 |
PCYC
PHARMACYCLICS INC
PCYC
|
$3.1M |
| 4 |
United Therapeutics
UTHR
|
$2.39M |
| 5 |
Amgen
AMGN
|
$1.93M |
Sector Composition
| 1 | Healthcare | 77.05% |
| 2 | Financials | 0.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCPT
1
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $4.23M | 3.55% | 25,679 +2,708 | +12% | +$447K |
|
|
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.16M | 3.48% | 55,988 +28,988 | +107% | +$2.15M |
|
|
SLXP
3
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $4.15M | 3.48% | 24,000 +5,813 | +32% | +$1M |
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.06M | 3.4% | 32,545 -11,186 | -26% | -$1.39M |
|
5
Incyte
INCY
$16.5B
| $4M | 3.36% | 43,682 -17,195 | -28% | -$1.58M |
|
|
MDVN
6
DELISTED
MEDIVATION, INC.
MDVN
| $3.97M | 3.33% | 30,747 -630 | -2% | -$81.3K |
|
7
Regeneron Pharmaceuticals
REGN
$61.5B
| $3.95M | 3.31% | 8,750 +100 | +1% | +$45.1K |
|
8
Biogen
BIIB
$19.4B
| $3.94M | 3.3% | 9,331 -155 | -2% | -$65.4K |
|
|
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.93M | 3.29% | 111,050 +28,797 | +35% | +$1.02M |
|
|
10
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.9M | 3.27% | 37,388 +19,513 | +109% | +$2.04M |
|
11
Ionis Pharmaceuticals
IONS
$6.79B
| $3.88M | 3.25% | 60,912 +15,494 | +34% | +$986K |
|
12
Vertex Pharmaceuticals
VRTX
$100B
| $3.87M | 3.24% | 32,805 +3,709 | +13% | +$438K |
|
|
CELG
13
DELISTED
Celgene Corp
CELG
| $3.84M | 3.22% | 33,289 +249 | +0.8% | +$28.7K |
|
14
Illumina
ILMN
$15.8B
| $3.83M | 3.21% | 20,609 +2,215 | +12% | +$411K |
|
|
ALXN
15
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.82M | 3.2% | 22,031 +3,699 | +20% | +$641K |
|
|
16
Alkermes
ALKS
$4.78B
| $3.81M | 3.2% | 62,546 +42,915 | +219% | +$2.62M |
|
17
Nektar Therapeutics
NKTR
$568M
| $3.69M | 3.09% | 335,650 +98,541 | +42% | +$1.08M |
|
|
PCYC
18
DELISTED
PHARMACYCLICS INC
PCYC
| $3.48M | 2.92% | 13,600 -12,123 | -47% | -$3.1M |
|
|
CPHD
19
DELISTED
Cepheid Inc
CPHD
| $3.11M | 2.61% | 54,693 -5,693 | -9% | -$324K |
|
|
20
Pacira BioSciences
PCRX
$1.2B
| $3.11M | 2.6% | +34,949 | New | +$3.11M |
|
21
Mettler-Toledo International
MTD
$26.8B
| $3.1M | 2.6% | 9,436 -564 | -6% | -$185K |
|
22
Bio-Techne
TECH
$8.5B
| $3.1M | 2.6% | 30,917 +3,017 | +11% | +$303K |
|
|
QGENF
23
DELISTED
QIAGEN NV
QGENF
| $3.09M | 2.59% | 122,724 +8,724 | +8% | +$220K |
|
|
24
ProShares Ultra NASDAQ Biotechnology
BIB
$53.6M
| $2.82M | 2.36% | 17,784 -20,400 | -53% | -$3.23M |
|
|
GEVA
25
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $1.73M | 1.45% | 17,700 -2,302 | -12% | -$224K |
|